Eyenovia, Inc. (NASDAQ: EYEN), is an ophthalmic technology company developing the Optejet® device for use both in connection with its own drug-device therapeutic product candidates for presbyopia and pediatric progressive myopia as well as out-licensing for additional indications.
Use this information to figure out if this company is an ideal customer for you.
'+1 813-766-9539
295 Madison Avenue
New York, 10017
51 - 200 Employees
$1M - $5M
linkedin.com/company/eyenoviabio
Eyenovia Inc.'s CEO is Michael Rowe
Eyenovia Inc.'s CFO is John Gandolfo
Eyenovia Inc.'s HQ is located at 295 Madison Avenue, New York
Eyenovia Inc.'s phone number is '+1 813-766-9539
Eyenovia Inc.'s official website is eyenovia.com
Eyenovia Inc.'s revenue is $1M - $5M
Eyenovia Inc. has 51 - 200 employees
Eyenovia Inc. is in the industry of: Pharmaceuticals
